Finance
The stock: Among the vaunted “critical minerals” required to effect the global energy transition away from fossil fuels, copper stands out. First, the world already produces and consumes a lot of it, enough that it’s known as “Dr. Copper” for...
In spinoff terms, Zenhub is a lot more Frasier than Joey. The Vancouver-based company was spun out of local innovation studio Axiom Zen in 2014 to help developers with collaboration and project management in the internet hosting service GitHub. At first...
BCBusiness + Baker Tilly Let’s face it: tax time can be stressful. Business owners who want to maximize their corporate and individual tax returns and avoid unnecessary costs can benefit from engaging a tax advisory professional. John Demetri CPA, Incorporated Partner, Tax, with...
If you’ve been following recent economic activity, it shouldn’t be a shock to hear that British Columbians could be in for some tough times in the next year. With inflation roaring and interest rates breaking records, it’s natural to assume...
We’ve long been intrigued by the Canadian crowdfunding startup FrontFundr. The Vancouver-based platform promised to revolutionize investing when it was founded in 2013, and some would argue it’s done just that. Since then, the company has built up a community of...
In anticipation of several more months of stock-market volatility, Scotiabank’s strategy team recently made a list of their “top-ranked quality stocks” for weathering the storm. The elite ranking included Burnaby-based Ritchie Bros. Auctioneers (TSX, NYSE:RBA). But hold on: the used heavy...
The stock: For years, clever financiers have tried to capture the statistically superior returns of private equity in a publicly traded security accessible to ordinary investors—that is, without the minimum investment thresholds, high fees and lock-in periods. Their efforts have...
The stock: For years, A&W Revenue Royalties Income Fund (TSX:AW.UN) was an income investor’s dream. In a time of low interest rates and dividend yields, the stock’s relatively frothy monthly distributions went down like a sweet root beer. Then the pandemic...
IVN shares have rallied nearly 60 percent over the past six months to $12.33 as of Tuesday’s close. Earlier this week, the company released its first development plan for Kamoa-Kakula since 2020, which was well received by analysts.
The stock: We were ready to consign Zymeworks (NASDAQ:ZYME) to the list of once brightly burning B.C.-based biotechs—it was at one point the most valuable life sciences startup in Canada—to ignominiously flame out. (See Quadra Logic Technologies, Angiotech Pharmaceuticals, Cardiome...